Presented By Sham Mailankody at 2016 ASCO Annual Meeting Genetic plasma cell signatures in high-risk smoldering myeloma versus multiple myeloma patients Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Massive genetic heterogeneity in <br />multiple myeloma Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Multiple myeloma consistently preceded by precursor states Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Slide 4 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Slide 5 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Patients and treatment response Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Samples and bioinformatic analysis Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Samples and bioinformatic analysis Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Slide 9 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Slide 10 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Significantly recurrent mutations in multiple myeloma Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Significantly recurrent mutations of individual genes in multiple myeloma Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Slide 13 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Slide 14 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Slide 15 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Slide 16 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Significantly recurrent mutations in multiple myeloma Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Recurrent mutations in the NF-kB pathway Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Number of patients with mutations in the NF-kB pathway genes Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Conclusions Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Conclusions (cont.) Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Myeloma Program at MSKCC Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Presented By Sham Mailankody at 2016 ASCO Annual Meeting Slide 23 Presented By Sham Mailankody at 2016 ASCO Annual Meeting
Thank you to our patients! Presented By Sham Mailankody at 2016 ASCO Annual Meeting